Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd

NAS:TLSA (Bermuda)   Ordinary Shares
$ 0.69 +0.0085 (+1.25%) 11:09 PM EST
At Loss
P/B:
34.50
Market Cap:
$ 71.64M
Enterprise V:
$ 70.69M
Volume:
146.44K
Avg Vol (2M):
387.15K
Trade In:
Volume:
146.44K
At Loss
Avg Vol (2M):
387.15K

Business Description

Tiziana Life Sciences Ltd logo
Tiziana Life Sciences Ltd
NAICS : 541714 SIC : 2834
ISIN : BMG889121031

Share Class Description:

TLSA: Ordinary Shares
Description
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Name Current Vs Industry Vs History
Cash-To-Debt 6.31
Equity-to-Asset 0.17
Debt-to-Equity 0.1
Debt-to-EBITDA -0.01
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 14.43
9-Day RSI 21.97
14-Day RSI 29.09
6-1 Month Momentum % 0.44
12-1 Month Momentum % 56.07

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.85
Quick Ratio 0.85
Cash Ratio 0.12

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.4
Shareholder Yield % 0.21
Name Current Vs Industry Vs History
ROE % -199.09
ROA % -101.52
ROIC % -254.12
ROC (Joel Greenblatt) % -5104.72
ROCE % -215.95

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 34.5
Price-to-Tangible-Book 34.5
EV-to-EBIT -4.61
EV-to-EBITDA -4.65
EV-to-FCF -20.28
Earnings Yield (Greenblatt) % -21.69
FCF Yield % -5.47

Financials (Next Earnings Date:2024-12-27 Est.)

TLSA's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TLSA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Tiziana Life Sciences Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.13
Beta 0.11
Volatility % 73.16
14-Day RSI 29.09
14-Day ATR ($) 0.09029
20-Day SMA ($) 0.921595
12-1 Month Momentum % 56.07
52-Week Range ($) 0.41 - 1.74
Shares Outstanding (Mil) 103.82

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Tiziana Life Sciences Ltd Filings

Filing Date Document Date Form
No Filing Data

Tiziana Life Sciences Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Tiziana Life Sciences Ltd Frequently Asked Questions

What is Tiziana Life Sciences Ltd(TLSA)'s stock price today?
The current price of TLSA is $0.69. The 52 week high of TLSA is $1.74 and 52 week low is $0.41.
When is next earnings date of Tiziana Life Sciences Ltd(TLSA)?
The next earnings date of Tiziana Life Sciences Ltd(TLSA) is 2024-12-27 Est..
Does Tiziana Life Sciences Ltd(TLSA) pay dividends? If so, how much?
Tiziana Life Sciences Ltd(TLSA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1